UK-based group UniChem, which has reached agreement on a proposed mergerwith France's Alliance Sante (Marketletter December 1), has said that the company's future deputy chairman, who is facing criminal proceedings in Italy, has UniChem's total support and confidence.
Stefano Pessina, who will hold approximately 36% of the shares in Alliance UniChem, is to face proceedings for aggravated fraudulent bankruptcy and aggravated fraud. The cases refer to a deal in 1990 when ICM Holding, in which Mr Pessina held a 40% stake, bought two firms from GEPI, an Italian state-owned company. Mr Pessina, who was not a director of ICM, held his stake through Alleanza Farmaceutica Europa.
After a preliminary investigation, the disrict attorney in Reggio, Calabria, said the case should be dropped as Mr Pessina was not involved in the fraud. A UniChem spokesman told the Marketletter that the issue was looked into in great depth when plans for the merger were being prepared, and that there is no case to answer with regards to Mr Pessina. UniChem says it is delighted to be connected with him.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze